Dr. Ueno on Liquid Biopsy

Naoto Tada Ueno, MD, PhD, FACP, from The University of Texas MD Anderson Cancer Center, discusses the advantages of liquid biopsy to detect and monitor tumor growth.

It is difficult to subject patients to multiple traditional biopsies due to the potential risks and burden of the patient, explains Ueno.

Liquid biopsies, which use circulating tumor cells (CTCs) and fragments of tumor DNA, provide a bigger picture of biological changes at the metastatic site, without using invasive techniques.